Sarepta Therapeutics Revenue, Growth & Competitor Profile

DBA SAREPTA

Company Profile & Annual Report for Sarepta Therapeutics

Access the complete profile.

Sarepta Therapeutics Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	Over 1,000Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 541711 Research & Development in Biotechnology
Address	215 1st St Cambridge, MA 02142

Sarepta Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Sarepta Therapeutics's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Sarepta Therapeutics is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Sarepta Therapeutics is a publicly traded company on NMS using the ticker symbol SRPT. Detailed information on company financials and operating reports can be found here: NMS: SRPT

Sarepta Therapeutics Annual Revenue and Growth Rate

Sarepta Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	Over $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Sarepta Therapeutics's revenues are gauged from an analysis of company filings.

Investor Activity

Sarepta Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
February 28, 2020	1	100%	$400 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Sarepta Therapeutics is developing and marketing. Sarepta Therapeutics's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
MYOPEPDYS (VESLETEPLIRSEN) INJECTION Medical training and teaching	01/23/2024
SAREPTA EXCHANGE Connecting healthcare providers with medical specialists and researchers to enable communication and consultation regarding health and medical treatment issues; Providing connections in the field of health care, namely, treatment of rare diseases; Physician and medical specialist connection services; Connections in the field of healthcare	05/25/2023
EVOPEPDYS Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases	04/18/2022

See all trademarks and details in the Full Report.

Market Share of Sarepta Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Sarepta Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Sarepta Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BIOGEN	Cambridge, MA	100
SAREPTA THERAPEUTICS	Cambridge, MA	36
AMYLYX PHARMACEUTICALS	Cambridge, MA	11
BRAINTREE LABORATORIES	Braintree, MA	8
FOGHORN THERAPEUTICS	Cambridge, MA	5
RECRUITMENT STRATEGIES GROUP	Stoneham, MA	4

Future Competition: Sarepta Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Sarepta Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)